Previous close | 104.46 |
Open | 105.46 |
Bid | 105.18 x 69000 |
Ask | 105.54 x 78000 |
Day's range | 105.06 - 105.52 |
52-week range | 85.56 - 111.28 |
Volume | |
Avg. volume | 561 |
Market cap | 182.833B |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 34.90 |
EPS (TTM) | 3.01 |
Earnings date | 17 Apr 2024 |
Forward dividend & yield | 2.05 (1.96%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
Abbott (NYSE: ABT) will announce its first-quarter 2024 financial results on Wednesday, April 17, before the market opens.
Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
In the closing of the recent trading day, Abbott (ABT) stood at $111.50, denoting a +1.35% change from the preceding trading day.